Sign Up Today and Learn More About Revagenix Stock
Invest in or calculate the value of your shares in Revagenix or other pre-IPO companies through EquityZen's platform.
Revagenix Stock (REVA)
Revagenix is a biopharmaceutical company discovering and developing therapies to address medical needs.
About Revagenix Stock
Founded
2019
Headquarters
San Mateo, CA, US
Industries
Science and Engineering, Health Care, Other
Revagenix Press Mentions
Stay in the know about the latest news on Revagenix
Broad spectrum aminoglycosides and uses thereof
patents • May 04, 2025
Broad spectrum aminoglycosides and uses thereof
patents • Apr 02, 2025
Revagenix describes new aminoglycosides to treat bacterial infections
bioworld • Mar 21, 2025
Modular synthesis of aminoglycosides
patents • Feb 12, 2025
Broad spectrum aminoglycosides and uses thereof
patents • Apr 13, 2024
Revagenix Management
Leadership team at Revagenix
Board Member
Bruce Montgomery
COO
Andrew McCandlish
Join now and verify your accreditation status to gain access to:
- Revagenix Current Valuation
- Revagenix Stock Price
- Revagenix Management
- Available deals in Revagenix and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Revagenix Cap Table and Funding History by Share Class and Liquidity Preferences
- Revagenix Revenue and Financials
- Revagenix Highlights
- Revagenix Business Model
- Revagenix Risk Factors
- Revagenix Research Report from SACRA Research
Trading Revagenix Stock
How to invest in Revagenix stock?
Accredited investors can buy pre-IPO stock in companies like Revagenix through EquityZen funds. These investments are made available by existing Revagenix shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Revagenix stock?
Shareholders can sell their Revagenix stock through EquityZen's private company marketplace. EquityZen's network includes over 370K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
